Jerome Feige at ARDD2025: Short talk: Novel nutrients targeting cellular hallmarks of aging

Value of the Information & Strength of the Argument

The talk provides valuable insights into the molecular mechanisms linking nutrition to aging, particularly in muscle. The argumentation is solid, based on a logical progression from human data to preclinical validation and back to a clinical pilot. The speaker presents specific data, including heat maps and functional assays, to support claims. The identification of oleuropein as a nutrient that can activate MCU is a novel finding with potential therapeutic implications. The discussion of challenges in translating preclinical findings to clinical outcomes adds credibility. However, the talk is concise and some details are omitted, but the overall argument is coherent and evidence-based.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with the speaker referencing published work and collaborations with academic institutions. The quality of sources is good, as the research appears to be peer-reviewed. The title accurately reflects the content. The talk is presented at a reputable conference (ARDD). The speaker does not explicitly cite specific papers, but mentions publications and collaborations, indicating a solid scientific foundation. The adequacy between title and content is excellent.

The title accurately reflects the content: a short talk on novel nutrients targeting cellular hallmarks of aging, focusing on mitochondrial calcium and oleuropein.

8/10

The talk presents original research from a reputable institution (Nestlé Research/EPFL) with a clear translational approach, including human biopsies, preclinical models, and a randomized controlled trial. The speaker describes specific molecular mechanisms and provides references to published work. However, the talk is a conference presentation and lacks detailed methodological transparency, and some claims are not fully substantiated in the talk itself.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction: Research focus on nutrition and muscle biology, linking hallmarks of aging to nutrition.
• 02:00Discussion of sarcopenia and its multifactorial nature, including molecular and environmental factors.
• 04:00Presentation of human biopsy data showing mitochondrial dysfunction as a key signature of sarcopenia.
• 06:00Discovery of trigonelline as a metabolite associated with muscle health and its link to NAD.
• 08:00Identification of MCUR1 downregulation in sarcopenia and its role in mitochondrial calcium transport.
• 10:00Screening for nutrients that activate MCU, leading to oleuropein as a potent activator.
• 12:00Molecular docking and in vitro binding studies showing oleuropein's interaction with MCU.
• 14:00Preclinical mouse studies demonstrating oleuropein's effects on mitochondrial function and muscle performance.
• 16:00Pilot clinical trial in older adults showing increased PDH activity but no significant functional improvement.

• Publication on trigonelline and sarcopenia — Mentioned as published work linking trigonelline to muscle health.
• Publication on MCU and oleuropein — Mentioned as a collaboration with University of Padova, likely published.

• Hallmarks of aging — The talk references the hallmarks of aging framework, which is a widely accepted review.